Levitra
Product Images NDC 54868-4984

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levitra (NDC 54868-4984). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levitra 10 mg Label (10mg Package Label)

Levitra 10 mg tablets packaging label from Physicians Total Care, Inc. The label states 6 tablets per container with active ingredient vardenafil HCL. It includes a federal caution against dispensing without prescription, storage instructions, lot number, expiration date, and manufacturer contact information.*

FDA Label Image

Levitra 20 mg Label (20mg Package Label)

Levitra 20 mg oral tablets packaging label by Physicians Total Care, Inc. The label shows the product name, active ingredient vardenafil HCL, strength of 20 mg, and package count of 10 tablets. It includes regulatory caution about prescription dispensing, expiration date, lot number, and storage instructions.*

FDA Label Image

Structural Formula (Bfc7a65d 372d 4748 8bb9 C5467a87207c 01)

Chemical structure of the active ingredient in Levitra, depicting a complex molecular structure including a sulfonamide and multiple ring systems, with the formula including x HCl x 3H2O indicating a hydrochloride trihydrate salt form.*

FDA Label Image

Figure 1 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 02)

A line graph showing plasma concentration (µg/L) over time (hours) for Levitra. The graph depicts a concentration peak shortly after administration, followed by a gradual decline over a 24-hour period, with error bars indicating variability at each time point.*

FDA Label Image

Figure 2 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 03)

A set of three line graphs showing mean changes in systolic blood pressure, diastolic blood pressure, and heart rate (bpm) over time relative to Vardenafil treatment, labeled with time points from 24 hours to 1 hour before treatment with Pre-NTG baselines. The graphs include error bars depicting variability in measurements.*

FDA Label Image

Figure 3 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 04)

A line graph depicting the mean change in mmHg over a 6-hour period for different groups: Placebo and Vardenafil at 5 mg and 6 mg doses, with comparisons between simultaneous administration and 6-hour separation. The x-axis represents time in hours, and the y-axis represents mean change in mmHg.*

FDA Label Image

Figure 4 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 05)

A line graph depicting mean change in mmHg over time (hours) comparing Placebo and Vardenafil 5 mg in both simultaneous and 8-hour separated dosing conditions. The graph shows four data series with distinct markers tracking mean blood pressure changes across a 6-hour period.*

FDA Label Image

Figure 5 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 06)

A line graph showing the mean change in blood pressure (mmHg) over time (hours). The graph compares placebo (Stage 1 and Stage 2) with Vardenafil 10 mg and 20 mg groups, depicting trends of decrease or fluctuation in blood pressure across a 6-hour period.*

FDA Label Image

Figure 6 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 07)

A line graph titled 'TERAZOSIN' showing mean change in mm Hg over time in hours. The graph compares placebo and two doses of Vardenafil (10 mg and 20 mg) under two conditions, 8-hour separation and simultaneous administration, with distinct markers for each group.*

FDA Label Image

Figure 7 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 08)

A line chart titled 'TAMSULOSIN' showing mean change (mmHg) on the y-axis versus time (hours) on the x-axis. It compares the effects of placebo and two doses (10 mg and 20 mg) of Vardenafil under different conditions labeled as '8hr Separation' and 'Simultaneous.' Multiple lines with distinct markers represent these groups over a 6-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.